The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
The targeted delivery of cancer drugs across the blood–brain barrier: chemical modifications of drugs or drug-nanoparticles?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
Micellar Nanocontainers Distribute to Defined Cytoplasmic Organelles
Savić, R., Luo, L., Eisenberg, A., & Maysinger, D. (2003) · Science · doi:10.1126/science.1078192 · Cited by 1,113
Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Persidsky, Y., Ramirez, S. H., Haorah, J., & Kanmogne, G. D. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9025-3 · Cited by 922
The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
Deeken, J. F., & Löscher, W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2854 · Cited by 721
Blood-brain barrier drug targeting: the future of brain drug development.
Pardridge, W. M. (2003) · Molecular Interventions · doi:10.1124/mi.3.2.90 · Cited by 570
Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations
Lee, G., Dallas, S., Hong, M., & Bendayan, R. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01513-8 · Cited by 539
Neurotrophic and Neuroprotective Actions of Estrogens and Their Therapeutic Implications
Lee, S. J., & McEwen, B. S. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.569 · Cited by 534
Chemoradiotherapy in Malignant Glioma: Standard of Care and Future Directions
Stupp, R., Hegi, M. E., Gilbert, M. R., & Chakravarti, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8554 · Cited by 529
Laske, D. W., Youle, R. J., & Oldfield, E. H. (1997) · Nature Medicine · doi:10.1038/nm1297-1362 · Cited by 525
Impact of Drug Transporter Studies on Drug Discovery and Development
Mizuno, N., Niwa, T., Yotsumoto, Y., & Sugiyama, Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.1 · Cited by 490
Structural and functional aspects of the blood-brain barrier
Begley, D. J., & Brightman, M. W. (2003) · Peptide Transport and Delivery into the Central Nervous System · doi:10.1007/978-3-0348-8049-7_2 · Cited by 445
Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles
Steiniger, S. C. J., Kreuter, J., Khalansky, A. S., Skidan, I. N., Bobruskin, A. I., Smirnova, Z. S., Severin, S. E., Uhl, R., Kock, M., Geiger, K. D., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20048 · Cited by 434
Active targeting of brain tumors using nanocarriers
Béduneau, A., Saulnier, P., & Benoit, J.-P. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.06.011 · Cited by 424
Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality Check
Muldoon, L. L., Soussain, C., Jahnke, K., Johanson, C., Siegal, T., Smith, Q. R., Hall, W. A., Hynynen, K., Senter, P. D., Peereboom, D. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.9861 · Cited by 417
Transporter-Mediated Permeation of Drugs Across the Blood–Brain Barrier
Tamai, I., & Tsuji, A. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1371::aid-jps1>3.0.co;2-d · Cited by 363
Influence of the Surface Properties on Nanoparticle-Mediated Transport of Drugs to the Brain
Kreuter, J. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2003.077 · Cited by 362
Micro and nano-fabrication of biodegradable polymers for drug delivery
Lu, Y., & Chen, S. C. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.05.002 · Cited by 340
Brain cancer diagnosis and therapy with nanoplatforms☆
KOO, Y., REDDY, G., BHOJANI, M., SCHNEIDER, R., PHILBERT, M., REHEMTULLA, A., ROSS, B., & KOPELMAN, R. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.012 · Cited by 326
Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel
Feng, S.-S., Mu, L., Win, K., & Huang, G. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455909 · Cited by 311
Petri, B., Bootz, A., Khalansky, A., Hekmatara, T., Müller, R., Uhl, R., Kreuter, J., & Gelperina, S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.015 · Cited by 298
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
Dallas, S., Miller, D. S., & Bendayan, R. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.3 · Cited by 296
Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs
Dubowchik, G. M., & Walker, M. A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00018-2 · Cited by 277
Molecular Trojan horses for blood–brain barrier drug delivery
PARDRIDGE, W. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.06.001 · Cited by 260
Brain uptake of thiamine-coated nanoparticles
Lockman, P. R., Oyewumi, M. O., Koziara, J. M., Roder, K. E., Mumper, R. J., & Allen, D. D. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.08.006 · Cited by 259
Polymeric nanoparticles for the drug delivery to the central nervous system
Tosi, G., Costantino, L., Ruozi, B., Forni, F., & Vandelli, M. A. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.2.155 · Cited by 232
Abulrob, A., Sprong, H., En Henegouwen, P. V. B., & Stanimirovic, D. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03463.x · Cited by 216
Bottom-up design of biomimetic assemblies
Tu, R. S., & Tirrell, M. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.047 · Cited by 209
Fenart, L., Casanova, A., Dehouck, B., Duhem, C., Slupek, S., Cecchelli, R., & Betbeder, D. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35204-8 · Cited by 196
Panyam, J., & Labhasetwar, V. (2004) · Molecular Pharmaceutics · doi:10.1021/mp034002c · Cited by 195
Lu, W., Wan, J., She, Z., & Jiang, X. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.015 · Cited by 193
The effect of the linker on the hydrolysis rate of drug-linked ester bonds
Schoenmakers, R. G., van de Wetering, P., Elbert, D. L., & Hubbell, J. A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.009 · Cited by 182
Interaction of Functionalized Superparamagnetic Iron Oxide Nanoparticles with Brain Structures
Cengelli, F., Maysinger, D., Tschudi-Monnet, F., Montet, X., Corot, C., Petri-Fink, A., Hofmann, H., & Juillerat-Jeanneret, L. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101915 · Cited by 177
Self-citationLarge Neutral Amino Acid Transporter Enables Brain Drug Delivery via Prodrugs
Gynther, M., Laine, K., Ropponen, J., Leppänen, J., Mannila, A., Nevalainen, T., Savolainen, J., Järvinen, T., & Rautio, J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701175d · Cited by 167
Development of neuropeptide drugs that cross the blood-brain barrier
Egleton, R. D., & Davis, T. P. (2004) · NeuroRx · doi:10.1602/neurorx.2.1.44 · Cited by 157
Jallouli, Y., Paillard, A., Chang, J., Sevin, E., & Betbeder, D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.023 · Cited by 139
Liposome targeting to mouse brain: Mannose as a recognition marker
Umezawa, F., & Yoshikatsu, E. T. O. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81333-0 · Cited by 139
Missirlis, D., Tirelli, N., & Hubbell, J. A. (2005) · Langmuir · doi:10.1021/la047367s · Cited by 115
Ambruosi, A., Gelperina, S. E., Khalansky, A. S., Tanski, S., Theisen, A., & Kreuter, J. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600788080 · Cited by 106
Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil
Soni, V., Kohli, D. V., & Jain, S. K. (2005) · Journal of drug targeting · doi:10.1080/10611860500107401 · Cited by 103
Penetration of intra-arterially administered vincristine in experimental brain tumor
Boyle, F. M., Eller, S., & Grossman, S. A. (2004) · Neuro-Oncology · doi:10.1215/s1152851703000516 · Cited by 102
Brigger, I., Morizet, J., Laudani, L., Aubert, G., Appel, M., Velasco, V., Terrier-Lacombe, M.-J., Desmaële, D., d’Angelo, J., Couvreur, P., et al. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.019 · Cited by 101
Use of nanoparticles for drug delivery in glioblastoma multiforme
Jain, K. K. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.4.363 · Cited by 99
Blood-Brain Barrier Transport of Reduced Folic Acid
Wu, D., & Pardridge, W. M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018829920158 · Cited by 94
Halmos, T., Santarromana, M., Antonakis, K., & Scherman, D. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00796-0 · Cited by 93
Juillerat‐Jeanneret, L., & Schmitt, F. (2006) · Medicinal Research Reviews · doi:10.1002/med.20086 · Cited by 90
Self-citationCornford, E. M., Young, D., Paxton, J. W., Finlay, G. J., Wilson, W. R., & Pardridge, W. M. (1992) · PubMed · Cited by 79
Surface modification of poly(glycolic acid) (PGA) for biomedical applications
Lee, K., Yoon, K. R., Woo, S. I., & Choi, I. S. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10556 · Cited by 78
The role of membrane transporters in drug delivery to brain tumors
Nies, A. T. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.023 · Cited by 64
Juillerat‐Jeanneret, L., Lohm, S., Hamou, M., & Pinet, F. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780100 · Cited by 31
Self-citationSakaeda, T., Siahaan, T. J., Audus, K. L., & Stella, V. J. (2000) · Journal of drug targeting · doi:10.3109/10611860008996865 · Cited by 23
Critical Analysis of Cancer Therapy using Nanomaterials
Juillerat‐Jeanneret, L. (2003) · Wiley eBooks · doi:10.1002/9783527610419.ntls0066 · Cited by 14
Self-citation
Cited by
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
Thermoresponsive Polymers for Biomedical Applications
Ward, M. A., & Georgiou, T. K. (2011) · Polymers · doi:10.3390/polym3031215 · Cited by 1,158
Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 1)
Honary, S., & Zahir, F. (2013) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v12i2.19 · Cited by 1,138
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
van Tellingen, O., Yetkin-Arik, B., de Gooijer, M. C., Wesseling, P., Wurdinger, T., & de Vries, H. E. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.02.002 · Cited by 1,035
Metadata
- Authors
- Juillerat-Jeanneret, L.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 13
- Issue
- 23-24
- Pages
- 1099-1106
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2152172559
- Cited by
- 314
- References
- 56
- FWCI
- 8.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.